TY - JOUR
T1 - Sustainability of task-shifting for antiretroviral treatment
AU - Naranbhai, Vivek
AU - Karim, Quarraisha Abdool
AU - Naidoo, Kogieleum
AU - Yende-Zuma, Nonhlanhla
AU - Karim, Salim S.Abdool
N1 - Funding Information:
This study was approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee. We gratefully acknowledge the contributions of the CAPRISA AIDS Treatment team for providing care. We thank the CAPRISA Vulindlela community advisory board and community of Vulindlela for supporting this programme and the Mahlase family for their leadership in inviting us to offer care in this community. We thank the KwaZulu-Natal Department of Health and the doctors and nurses at the Mafakathini primary care clinic for their professional support in clinical care. Patient care in the CAPRISA AIDS Treatment project is supported by the KwaZulu-Natal Department of Health, the Global Fund to fight AIDS, Tuberculosis and Malaria, and the US President's Emergency Plan for AIDS Relief (PEPFAR). The US National Institutes for Health's Comprehensive International Program of Research on AIDS (CIPRA, grant # AI51794 ) provided research infrastructure. VN was supported by LIFELab and the Columbia University—South Africa Fogarty AIDS International Training and Research Program (AITRP, grant # D43 TW000231 ). SSAK is a member of the PEPFAR Scientific Advisory Board and the WHO Strategic Use of Antiretrovirals Committee. The other authors declare that they have no conflicts of interest.
PY - 2012/12
Y1 - 2012/12
UR - http://www.scopus.com/inward/record.url?scp=84870279062&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(12)62110-2
DO - 10.1016/S0140-6736(12)62110-2
M3 - Letter
C2 - 23200500
AN - SCOPUS:84870279062
SN - 0140-6736
VL - 380
SP - 1907
EP - 1908
JO - The Lancet
JF - The Lancet
IS - 9857
ER -